Thomas Attard
Concepts (313)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Adenomatous Polyposis Coli | 18 | 2023 | 25 | 5.900 |
Why?
| Colorectal Neoplasms | 6 | 2024 | 28 | 3.580 |
Why?
| Child | 52 | 2024 | 3257 | 3.000 |
Why?
| Humans | 69 | 2024 | 6797 | 2.930 |
Why?
| Adolescent | 33 | 2024 | 2137 | 2.190 |
Why?
| Polyps | 5 | 2024 | 6 | 2.140 |
Why?
| Gastrointestinal Hemorrhage | 5 | 2020 | 15 | 2.090 |
Why?
| Neoplastic Syndromes, Hereditary | 4 | 2023 | 5 | 1.970 |
Why?
| Colonoscopy | 11 | 2024 | 15 | 1.940 |
Why?
| Colonic Polyps | 3 | 2023 | 5 | 1.900 |
Why?
| Child, Preschool | 27 | 2022 | 1503 | 1.820 |
Why?
| Male | 35 | 2022 | 3328 | 1.810 |
Why?
| Endoscopy, Gastrointestinal | 4 | 2018 | 20 | 1.800 |
Why?
| Capsule Endoscopy | 3 | 2023 | 4 | 1.670 |
Why?
| Female | 34 | 2022 | 3599 | 1.670 |
Why?
| Foreign Bodies | 3 | 2021 | 23 | 1.670 |
Why?
| Inpatients | 3 | 2022 | 45 | 1.660 |
Why?
| Intestinal Polyposis | 5 | 2023 | 6 | 1.540 |
Why?
| Endoscopy | 4 | 2020 | 15 | 1.520 |
Why?
| Stomach Neoplasms | 4 | 2023 | 6 | 1.520 |
Why?
| Pediatrics | 5 | 2020 | 175 | 1.490 |
Why?
| Emergency Service, Hospital | 3 | 2019 | 130 | 1.360 |
Why?
| Retrospective Studies | 17 | 2022 | 1332 | 1.340 |
Why?
| Mutation | 9 | 2019 | 199 | 1.280 |
Why?
| Infant | 17 | 2022 | 1449 | 1.230 |
Why?
| Appendix | 2 | 2023 | 12 | 1.120 |
Why?
| Genetic Counseling | 4 | 2016 | 8 | 1.120 |
Why?
| Microbiota | 2 | 2022 | 9 | 1.110 |
Why?
| United States | 8 | 2022 | 656 | 1.100 |
Why?
| Adult | 13 | 2022 | 1259 | 1.050 |
Why?
| Adenomatous Polyposis Coli Protein | 3 | 2018 | 5 | 1.050 |
Why?
| Proton Pump Inhibitors | 2 | 2023 | 13 | 0.980 |
Why?
| Cohort Studies | 7 | 2022 | 274 | 0.980 |
Why?
| Databases, Factual | 6 | 2022 | 106 | 0.950 |
Why?
| Fractures, Bone | 2 | 2022 | 36 | 0.950 |
Why?
| Consensus | 4 | 2021 | 31 | 0.920 |
Why?
| Hospitalization | 3 | 2022 | 194 | 0.910 |
Why?
| Gastrointestinal Neoplasms | 5 | 2019 | 7 | 0.890 |
Why?
| Colonic Neoplasms | 1 | 2022 | 7 | 0.890 |
Why?
| Malnutrition | 1 | 2022 | 9 | 0.860 |
Why?
| Histamine H2 Antagonists | 1 | 2022 | 8 | 0.860 |
Why?
| Histamine | 1 | 2022 | 11 | 0.850 |
Why?
| Peutz-Jeghers Syndrome | 4 | 2019 | 6 | 0.830 |
Why?
| Electronic Health Records | 1 | 2022 | 62 | 0.810 |
Why?
| Patient Transfer | 1 | 2021 | 9 | 0.810 |
Why?
| Disease Management | 1 | 2021 | 36 | 0.790 |
Why?
| Quality of Life | 1 | 2022 | 134 | 0.790 |
Why?
| Societies, Medical | 1 | 2021 | 47 | 0.790 |
Why?
| Risk Factors | 6 | 2022 | 470 | 0.770 |
Why?
| Young Adult | 7 | 2019 | 665 | 0.750 |
Why?
| Orthodontic Wires | 1 | 2019 | 1 | 0.740 |
Why?
| Orthodontics | 1 | 2019 | 1 | 0.740 |
Why?
| Self-Injurious Behavior | 1 | 2019 | 2 | 0.740 |
Why?
| Autism Spectrum Disorder | 1 | 2020 | 28 | 0.740 |
Why?
| Endoscopy, Digestive System | 2 | 2018 | 8 | 0.740 |
Why?
| Biomass | 2 | 2018 | 2 | 0.720 |
Why?
| Cholecystitis | 1 | 2019 | 6 | 0.720 |
Why?
| Hospitals, Pediatric | 2 | 2019 | 183 | 0.690 |
Why?
| Cathartics | 1 | 2018 | 4 | 0.680 |
Why?
| Polyethylene Glycols | 1 | 2018 | 12 | 0.680 |
Why?
| Gastrostomy | 1 | 2019 | 68 | 0.680 |
Why?
| Genetic Predisposition to Disease | 6 | 2015 | 224 | 0.660 |
Why?
| Postoperative Complications | 1 | 2019 | 194 | 0.620 |
Why?
| Genetic Testing | 6 | 2019 | 81 | 0.600 |
Why?
| Early Detection of Cancer | 1 | 2016 | 8 | 0.580 |
Why?
| Patient Readmission | 1 | 2017 | 68 | 0.580 |
Why?
| Age Distribution | 4 | 2019 | 32 | 0.580 |
Why?
| Length of Stay | 4 | 2022 | 243 | 0.560 |
Why?
| Intestinal Polyps | 3 | 2019 | 3 | 0.550 |
Why?
| Zea mays | 1 | 2015 | 1 | 0.550 |
Why?
| Waxes | 1 | 2015 | 1 | 0.550 |
Why?
| Carbon Dioxide | 1 | 2015 | 17 | 0.540 |
Why?
| Pedigree | 6 | 2019 | 56 | 0.540 |
Why?
| Treatment Outcome | 6 | 2019 | 667 | 0.540 |
Why?
| Biopsy | 4 | 2022 | 59 | 0.490 |
Why?
| Internship and Residency | 2 | 2015 | 33 | 0.470 |
Why?
| Barrett Esophagus | 1 | 2013 | 1 | 0.470 |
Why?
| Esophageal Diseases | 1 | 2013 | 1 | 0.470 |
Why?
| Age Factors | 4 | 2018 | 215 | 0.470 |
Why?
| Collagen | 1 | 2013 | 3 | 0.460 |
Why?
| Esophagitis | 1 | 2013 | 7 | 0.460 |
Why?
| Gastritis | 1 | 2013 | 8 | 0.460 |
Why?
| Stomach | 1 | 2013 | 15 | 0.460 |
Why?
| Esophagus | 1 | 2013 | 32 | 0.450 |
Why?
| Adenomatous Polyps | 2 | 2023 | 2 | 0.440 |
Why?
| Genes, APC | 2 | 2015 | 3 | 0.440 |
Why?
| Elective Surgical Procedures | 3 | 2020 | 14 | 0.410 |
Why?
| Appointments and Schedules | 2 | 2020 | 13 | 0.380 |
Why?
| Celiac Disease | 3 | 2017 | 4 | 0.380 |
Why?
| Coronavirus Infections | 2 | 2020 | 16 | 0.380 |
Why?
| Pneumonia, Viral | 2 | 2020 | 17 | 0.380 |
Why?
| Duodenal Neoplasms | 2 | 2016 | 2 | 0.380 |
Why?
| Digestive System Surgical Procedures | 2 | 2020 | 45 | 0.370 |
Why?
| Crohn Disease | 2 | 2011 | 22 | 0.350 |
Why?
| Gastrointestinal Diseases | 2 | 2020 | 55 | 0.340 |
Why?
| Clinical Competence | 1 | 2009 | 35 | 0.340 |
Why?
| Mass Screening | 2 | 2019 | 41 | 0.340 |
Why?
| Recurrence | 2 | 2019 | 123 | 0.330 |
Why?
| Acute Disease | 2 | 2019 | 71 | 0.320 |
Why?
| Colectomy | 4 | 2016 | 13 | 0.320 |
Why?
| Cytoskeletal Proteins | 1 | 2007 | 3 | 0.320 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2009 | 81 | 0.320 |
Why?
| DNA, Neoplasm | 1 | 2007 | 7 | 0.320 |
Why?
| Comorbidity | 2 | 2019 | 64 | 0.320 |
Why?
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2007 | 2 | 0.320 |
Why?
| Molecular Biology | 1 | 2007 | 3 | 0.320 |
Why?
| Time Factors | 2 | 2019 | 247 | 0.300 |
Why?
| Genetics, Population | 1 | 2007 | 11 | 0.300 |
Why?
| Prevalence | 3 | 2022 | 149 | 0.300 |
Why?
| Brain Neoplasms | 1 | 2007 | 44 | 0.290 |
Why?
| Syndrome | 2 | 2021 | 33 | 0.290 |
Why?
| Chronic Disease | 2 | 2019 | 104 | 0.280 |
Why?
| Fibromatosis, Aggressive | 2 | 2016 | 3 | 0.280 |
Why?
| Risk Assessment | 3 | 2019 | 137 | 0.270 |
Why?
| Cross-Sectional Studies | 3 | 2022 | 319 | 0.270 |
Why?
| Abdominal Pain | 2 | 2018 | 72 | 0.260 |
Why?
| Practice Guidelines as Topic | 3 | 2017 | 97 | 0.250 |
Why?
| Ileitis | 1 | 2004 | 3 | 0.250 |
Why?
| Jejunal Diseases | 1 | 2004 | 3 | 0.250 |
Why?
| Nutritional Support | 1 | 2004 | 5 | 0.250 |
Why?
| Prognosis | 4 | 2007 | 213 | 0.250 |
Why?
| Neoplasms | 2 | 2019 | 120 | 0.250 |
Why?
| Eating | 2 | 2021 | 31 | 0.240 |
Why?
| Incidental Findings | 1 | 2023 | 9 | 0.230 |
Why?
| Patient Selection | 2 | 2020 | 42 | 0.230 |
Why?
| Intussusception | 2 | 2019 | 15 | 0.230 |
Why?
| Hamartoma | 1 | 2003 | 4 | 0.230 |
Why?
| Pandemics | 2 | 2020 | 85 | 0.230 |
Why?
| Tumor Microenvironment | 1 | 2022 | 14 | 0.230 |
Why?
| Ileum | 2 | 2019 | 18 | 0.220 |
Why?
| Gastroenterology | 2 | 2019 | 17 | 0.220 |
Why?
| Sex Distribution | 2 | 2018 | 18 | 0.220 |
Why?
| Health Care Surveys | 2 | 2015 | 33 | 0.220 |
Why?
| Neoplasms, Glandular and Epithelial | 1 | 2003 | 49 | 0.220 |
Why?
| Longitudinal Studies | 1 | 2022 | 126 | 0.220 |
Why?
| Hospitals | 1 | 2022 | 39 | 0.220 |
Why?
| Electric Power Supplies | 1 | 2021 | 4 | 0.210 |
Why?
| Enterobacteriaceae Infections | 1 | 2021 | 10 | 0.210 |
Why?
| Stem Cells | 1 | 2021 | 19 | 0.210 |
Why?
| Drug Administration Schedule | 2 | 2018 | 41 | 0.210 |
Why?
| Colitis | 1 | 2021 | 13 | 0.210 |
Why?
| Appendectomy | 1 | 2023 | 109 | 0.210 |
Why?
| Diet | 1 | 2021 | 55 | 0.200 |
Why?
| Adenocarcinoma | 1 | 2001 | 8 | 0.200 |
Why?
| Pharmacogenetics | 1 | 2023 | 172 | 0.200 |
Why?
| Algorithms | 4 | 2021 | 106 | 0.200 |
Why?
| Meckel Diverticulum | 1 | 2020 | 8 | 0.200 |
Why?
| Obesity | 1 | 2022 | 135 | 0.200 |
Why?
| Digestive System | 1 | 2020 | 1 | 0.190 |
Why?
| Ileal Diseases | 1 | 2000 | 8 | 0.190 |
Why?
| Hepatoblastoma | 2 | 2019 | 7 | 0.190 |
Why?
| Communicable Disease Control | 1 | 2020 | 7 | 0.190 |
Why?
| Phenotype | 3 | 2013 | 244 | 0.190 |
Why?
| Cystic Fibrosis | 1 | 2000 | 18 | 0.190 |
Why?
| Odds Ratio | 1 | 2020 | 53 | 0.190 |
Why?
| Laparoscopy | 2 | 2020 | 242 | 0.190 |
Why?
| Bioethical Issues | 1 | 2019 | 3 | 0.190 |
Why?
| Personal Autonomy | 1 | 2019 | 4 | 0.190 |
Why?
| Secondary Prevention | 1 | 2019 | 7 | 0.180 |
Why?
| Mortality | 1 | 2019 | 3 | 0.180 |
Why?
| Neoplasm Recurrence, Local | 1 | 2019 | 34 | 0.180 |
Why?
| Disease Progression | 1 | 2019 | 105 | 0.180 |
Why?
| Duodenum | 1 | 2019 | 20 | 0.180 |
Why?
| Enteral Nutrition | 1 | 2019 | 65 | 0.170 |
Why?
| Infant, Newborn | 2 | 2019 | 828 | 0.170 |
Why?
| Chlorine | 1 | 2018 | 1 | 0.170 |
Why?
| Steam | 1 | 2018 | 1 | 0.170 |
Why?
| Phenol | 1 | 2018 | 1 | 0.170 |
Why?
| Soot | 1 | 2018 | 1 | 0.170 |
Why?
| Laxatives | 1 | 2018 | 5 | 0.170 |
Why?
| Inflammatory Bowel Diseases | 1 | 2019 | 42 | 0.170 |
Why?
| Patient Discharge | 1 | 2019 | 60 | 0.170 |
Why?
| Hospital Charges | 1 | 2018 | 11 | 0.170 |
Why?
| Social Class | 1 | 2018 | 10 | 0.170 |
Why?
| Administration, Oral | 1 | 2018 | 62 | 0.170 |
Why?
| Respiratory Tract Diseases | 1 | 2018 | 8 | 0.170 |
Why?
| Gastric Mucosa | 2 | 2013 | 14 | 0.170 |
Why?
| Magnetic Resonance Imaging | 1 | 2019 | 116 | 0.170 |
Why?
| Fever | 1 | 2018 | 27 | 0.170 |
Why?
| Hypercalcemia | 1 | 1998 | 10 | 0.170 |
Why?
| Mandibular Neoplasms | 1 | 2018 | 2 | 0.160 |
Why?
| Osteosclerosis | 1 | 2018 | 2 | 0.160 |
Why?
| Dentofacial Deformities | 1 | 2018 | 2 | 0.160 |
Why?
| Osteoma | 1 | 2018 | 3 | 0.160 |
Why?
| Urban Population | 1 | 2018 | 36 | 0.160 |
Why?
| Sex Factors | 1 | 2018 | 78 | 0.160 |
Why?
| Diphosphonates | 1 | 1998 | 13 | 0.160 |
Why?
| Rural Population | 1 | 2018 | 38 | 0.160 |
Why?
| Liver Diseases | 1 | 1998 | 17 | 0.160 |
Why?
| Double-Balloon Enteroscopy | 1 | 2017 | 1 | 0.160 |
Why?
| Ambulatory Care | 1 | 2018 | 46 | 0.160 |
Why?
| Aged | 3 | 2020 | 376 | 0.160 |
Why?
| Patient Compliance | 1 | 2018 | 71 | 0.160 |
Why?
| Genotyping Techniques | 2 | 2017 | 21 | 0.160 |
Why?
| Liver Transplantation | 1 | 1998 | 43 | 0.150 |
Why?
| Patient Admission | 1 | 2017 | 9 | 0.150 |
Why?
| Diarrhea, Infantile | 1 | 2017 | 2 | 0.150 |
Why?
| Multivariate Analysis | 1 | 2017 | 75 | 0.150 |
Why?
| Liver Neoplasms | 1 | 2016 | 15 | 0.150 |
Why?
| Vomiting | 2 | 2014 | 24 | 0.150 |
Why?
| Prophylactic Surgical Procedures | 1 | 2016 | 2 | 0.150 |
Why?
| Chemoprevention | 1 | 2016 | 4 | 0.150 |
Why?
| Thyroid Neoplasms | 1 | 2016 | 2 | 0.150 |
Why?
| Intestinal Mucosa | 1 | 2017 | 36 | 0.150 |
Why?
| Guideline Adherence | 1 | 2017 | 34 | 0.150 |
Why?
| Electronic Mail | 1 | 2015 | 2 | 0.140 |
Why?
| Canada | 1 | 2015 | 31 | 0.140 |
Why?
| Needs Assessment | 1 | 2015 | 21 | 0.140 |
Why?
| Curriculum | 1 | 2015 | 21 | 0.140 |
Why?
| Plant Leaves | 1 | 2015 | 2 | 0.140 |
Why?
| Fellowships and Scholarships | 1 | 2015 | 20 | 0.140 |
Why?
| Biomarkers, Tumor | 1 | 2015 | 63 | 0.130 |
Why?
| Evidence-Based Medicine | 3 | 2019 | 43 | 0.130 |
Why?
| Registries | 2 | 2007 | 87 | 0.130 |
Why?
| Biopsy, Needle | 2 | 2006 | 3 | 0.120 |
Why?
| Serologic Tests | 1 | 2014 | 6 | 0.120 |
Why?
| Genotype | 2 | 2023 | 401 | 0.120 |
Why?
| Intestine, Small | 1 | 2014 | 15 | 0.120 |
Why?
| Deglutition Disorders | 1 | 2013 | 2 | 0.120 |
Why?
| Failure to Thrive | 1 | 2013 | 7 | 0.120 |
Why?
| Anemia, Iron-Deficiency | 1 | 2013 | 5 | 0.120 |
Why?
| Chromosomes, Human, Pair 10 | 1 | 2013 | 1 | 0.110 |
Why?
| Drug Therapy, Combination | 1 | 2013 | 41 | 0.110 |
Why?
| Chromosome Deletion | 1 | 2013 | 15 | 0.110 |
Why?
| Predictive Value of Tests | 1 | 2013 | 104 | 0.110 |
Why?
| Gastric Fundus | 2 | 2023 | 3 | 0.110 |
Why?
| Follow-Up Studies | 2 | 2017 | 327 | 0.110 |
Why?
| Dyspepsia | 1 | 2013 | 48 | 0.110 |
Why?
| Aged, 80 and over | 2 | 2020 | 150 | 0.110 |
Why?
| Prospective Studies | 3 | 2019 | 522 | 0.110 |
Why?
| Severity of Illness Index | 2 | 2019 | 144 | 0.100 |
Why?
| Mediterranean Region | 3 | 2017 | 3 | 0.100 |
Why?
| Radiography, Panoramic | 2 | 2021 | 3 | 0.090 |
Why?
| Phenylhydrazines | 1 | 2009 | 1 | 0.090 |
Why?
| Mesalamine | 1 | 2009 | 3 | 0.090 |
Why?
| Anti-Inflammatory Agents | 1 | 2009 | 11 | 0.090 |
Why?
| Colon | 1 | 2009 | 13 | 0.090 |
Why?
| Colitis, Ulcerative | 1 | 2009 | 10 | 0.090 |
Why?
| Internet | 1 | 2009 | 16 | 0.090 |
Why?
| Germ-Line Mutation | 1 | 2007 | 10 | 0.080 |
Why?
| DNA Mutational Analysis | 1 | 2007 | 39 | 0.080 |
Why?
| Codon | 1 | 2007 | 2 | 0.080 |
Why?
| Asia | 1 | 2007 | 9 | 0.080 |
Why?
| Surveys and Questionnaires | 1 | 2009 | 297 | 0.080 |
Why?
| Europe | 1 | 2007 | 33 | 0.080 |
Why?
| North America | 1 | 2007 | 47 | 0.080 |
Why?
| Immunohistochemistry | 1 | 2006 | 46 | 0.070 |
Why?
| Monitoring, Physiologic | 1 | 2006 | 24 | 0.070 |
Why?
| Transglutaminases | 2 | 2017 | 3 | 0.070 |
Why?
| GTP-Binding Proteins | 2 | 2017 | 7 | 0.070 |
Why?
| HLA Antigens | 2 | 2017 | 12 | 0.070 |
Why?
| Precancerous Conditions | 1 | 2004 | 7 | 0.060 |
Why?
| Reproducibility of Results | 1 | 2004 | 201 | 0.060 |
Why?
| Cytochrome P-450 CYP2C19 | 1 | 2023 | 55 | 0.060 |
Why?
| Gastroscopy | 1 | 2002 | 1 | 0.050 |
Why?
| Maryland | 1 | 2002 | 3 | 0.050 |
Why?
| Fermentation | 1 | 2021 | 2 | 0.050 |
Why?
| Pectins | 1 | 2021 | 2 | 0.050 |
Why?
| Biodiversity | 1 | 2021 | 2 | 0.050 |
Why?
| Mucin-2 | 1 | 2021 | 2 | 0.050 |
Why?
| Regeneration | 1 | 2021 | 3 | 0.050 |
Why?
| Butyrates | 1 | 2021 | 3 | 0.050 |
Why?
| Epithelium | 1 | 2021 | 6 | 0.050 |
Why?
| Citrobacter rodentium | 1 | 2021 | 4 | 0.050 |
Why?
| Receptors, G-Protein-Coupled | 1 | 2021 | 7 | 0.050 |
Why?
| HEK293 Cells | 1 | 2021 | 31 | 0.050 |
Why?
| Triglycerides | 1 | 2021 | 23 | 0.050 |
Why?
| Middle Aged | 1 | 2004 | 651 | 0.050 |
Why?
| Transcription, Genetic | 1 | 2021 | 48 | 0.050 |
Why?
| Cell Proliferation | 1 | 2021 | 56 | 0.050 |
Why?
| Promoter Regions, Genetic | 1 | 2021 | 57 | 0.050 |
Why?
| Mice, Inbred C57BL | 1 | 2021 | 89 | 0.050 |
Why?
| Incidence | 1 | 2002 | 132 | 0.050 |
Why?
| Gene Expression Profiling | 1 | 2021 | 113 | 0.050 |
Why?
| Gene Expression Regulation | 1 | 2021 | 102 | 0.050 |
Why?
| Gastrectomy | 1 | 2001 | 1 | 0.050 |
Why?
| Mice | 1 | 2021 | 312 | 0.050 |
Why?
| Triage | 1 | 2020 | 6 | 0.050 |
Why?
| Cecum | 1 | 2000 | 5 | 0.050 |
Why?
| Anastomosis, Surgical | 1 | 2000 | 24 | 0.050 |
Why?
| Symptom Assessment | 1 | 2020 | 12 | 0.050 |
Why?
| Radiography | 1 | 2000 | 41 | 0.050 |
Why?
| Gastrointestinal Transit | 1 | 2020 | 1 | 0.050 |
Why?
| Animals | 1 | 2021 | 664 | 0.040 |
Why?
| Adenoma | 1 | 2019 | 3 | 0.040 |
Why?
| Sequence Deletion | 1 | 2019 | 8 | 0.040 |
Why?
| Mutation, Missense | 1 | 2019 | 26 | 0.040 |
Why?
| Multiplex Polymerase Chain Reaction | 1 | 2019 | 9 | 0.040 |
Why?
| Sensitivity and Specificity | 1 | 2019 | 147 | 0.040 |
Why?
| Sequence Analysis, DNA | 1 | 2019 | 115 | 0.040 |
Why?
| Osteoclasts | 1 | 1998 | 4 | 0.040 |
Why?
| Jaw | 1 | 2018 | 2 | 0.040 |
Why?
| Parenteral Nutrition, Total | 1 | 1998 | 7 | 0.040 |
Why?
| Case-Control Studies | 1 | 2018 | 205 | 0.040 |
Why?
| Feasibility Studies | 1 | 2017 | 67 | 0.040 |
Why?
| Connective Tissue | 1 | 2017 | 2 | 0.040 |
Why?
| Autoantibodies | 1 | 2017 | 9 | 0.040 |
Why?
| Health Resources | 1 | 2017 | 17 | 0.040 |
Why?
| Self Report | 1 | 2016 | 43 | 0.040 |
Why?
| Intestines | 1 | 2017 | 26 | 0.040 |
Why?
| Africa, Northern | 1 | 2014 | 1 | 0.030 |
Why?
| Europe, Eastern | 1 | 2014 | 1 | 0.030 |
Why?
| Anorexia | 1 | 2014 | 2 | 0.030 |
Why?
| Antibodies | 1 | 2014 | 15 | 0.030 |
Why?
| Diarrhea | 1 | 2014 | 18 | 0.030 |
Why?
| Weight Loss | 1 | 2014 | 40 | 0.030 |
Why?
| Haplotypes | 1 | 2014 | 81 | 0.030 |
Why?
| Chromosomes, Human, Pair 1 | 1 | 2013 | 3 | 0.030 |
Why?
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2013 | 2 | 0.030 |
Why?
| PTEN Phosphohydrolase | 1 | 2013 | 7 | 0.030 |
Why?
| Health Care Costs | 1 | 2011 | 31 | 0.030 |
Why?
| Aminosalicylic Acids | 1 | 2009 | 1 | 0.020 |
Why?
| Double-Blind Method | 1 | 2009 | 49 | 0.020 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|